Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Berta
Berta Kotar-Jordan, Kostanjevica Na Krki SI
| Patent application number | Description | Published |
|---|---|---|
| 20090130205 | Solid Pharmaceutical Composition Comprising Donepezil Hydrochloride - The invention relates to a solid pharmaceutical composition comprising donepezil hydrochloride hydrate and a process for its preparation. In particular it relates to a composition and a process wherein the donepezil hydrochloride retains its polymorphic form and is therefore highly stable against conversion into other polymorphic forms. | 05-21-2009 |
| 20100317694 | Solid pharmaceutical composition comprising donepezil hydrochloride - The invention relates to a solid pharmaceutical composition comprising donepezil hydrochloride hydrate and a process for its preparation. In particular it relates to a composition and a process wherein the donepezil hydrochloride retains its polymorphic form and is therefore highly stable against conversion into other polymorphic forms. | 12-16-2010 |
Berta Ponsati Obiols, Gava-Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100021510 | NEURONAL EXOCYTOSIS INHIBITING PEPTIDES - The invention relates to peptides of general formula (I): | 01-28-2010 |
Berta Ponsati Obiols, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20110166071 | METHOD FOR SYNTHESIZING THYMOSINS - The invention relates to a method for obtaining thymosins and/or the pharmaceutically acceptable salts thereof by means of solid-phase synthesis on polymeric supports, which comprises the steps of linearly synthesizing the thymus-derived peptides in solid phase, incorporating at least one Thr or Ser in the sequence, in pseudoproline dipeptide form, obtaining the thymosins by treating the peptidyl resin with trifluoroacetic acid, and purifying the thymosins by RP-HPLC. The present invention also protects the isolated and/or purified compound obtained by means of said method and also the use thereof in the preparation of a medicinal product. | 07-07-2011 |
| 20120122781 | PEPTIDE LIGANDS OF SOMATOSTATIN RECEPTORS - Peptide derivatives, their stereoisomers, mixtures thereof and/or their pharmaceutically acceptable salts, a method of obtaining them, pharmaceutical compositions containing them and the use thereof for the treatment, prevention and/or diagnosis of those conditions, disorders and/or pathologies in which the sstr1, sstr2, sstr3, sstr4 and/or sstr5 somatostatin receptors are expressed. | 05-17-2012 |
Berta Ponsati Obliols, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20110206752 | COMPOSITIONS FOR THE TREATMENT OF PAIN AND/OR INFLAMATION - Compositions for the treatment of pain and/or inflammation comprising at least one peptide with the general formula (I) R1-AA-R2, its stereoisomers, mixtures thereof, and its cosmetically and pharmaceutically acceptable salts. Peptide with general formula (I), its stereoisomers, mixtures thereof, and its cosmetically and pharmaceutically acceptable salts for the treatment of pain and/or inflammation. | 08-25-2011 |
Berta Rodes, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20100047281 | VARIANTS OF HEPATITIS B VIRUS WITH RESISTANCE TO ANTI-VIRAL NUCLEOSIDE AGENTS AND APPLICATIONS THEREOF - The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside or nucleotide analogs or other antagonists of HBV DNA polymerase activity and/or reduced interactivity with antibodies to viral surface components including reduced sensitivity to these antibodies. The present invention further contemplates assays for detecting such viral variants. These assays are useful in monitoring anti-viral therapeutic regimens and in developing new or modified vaccines directed against viral agents and in particular the resistant HBV variants of the present invention. The present invention also contemplates the use of the viral variants to screen for agents capable of inhibiting infection, replication and/or release of the virus. | 02-25-2010 |
Berta Strulovici, So. San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120122212 | TGF-BETA PATHWAY INHIBITORS FOR ENHANCEMENT OF CELLULAR REPROGRAMMING OF HUMAN CELLS - The present disclosure provides methods and compositions to enhance reprogramming in human cells. In some cases, the method includes contacting human cells with an inhibitor of the TGFβ pathway, for example a TGFβ receptor (TGFβR) inhibitor in combination with one or more induction factors. | 05-17-2012 |